Infective endocarditis; report from a main referral teaching hospital in Iran

Background/Objective: The aim of the present preliminary study was to assess the demographic, clinical, paraclinical, microbiological, echocardiographic, and therapeutic profile as well as in-hospital outcome of patients with infective endocarditis at a referral center for various infectious diseases in Iran. Methods: Required demographic, clinical, plausible complications and paraclinical data were collected from patients’ medical charts. Echocardiographic findings were obtained by performing transthoracic and/or transesophageal echocardiography as clinically indicated. In addition, details of management modalities and in-hospital outcome of patients were recorded. Results: During a 3-year period, 55 patients with definite or possible diagnosis of Infective endocarditis were admitted to the ward. Twenty one (38.2%) patients were injection drug users. Staphylococcus aureus and S.epidermidis were the most commonly isolated microorganisms. Management modalities of Infective endocarditis included antimicrobial therapy alone (48 cases) and the combination of antimicrobial therapy and surgery (7 cases). Conclusion: The rate of negative blood culture in our cohort is high. S. aureus and S.epidermidis were the most commonly isolated microorganisms from positive blood cultures. Congestive heart failure was the most frequent infective endocarditis complication as well as indication for surgery. In-hospital mortality rate of patients was unexpectedly low.

[1]  T. Bashore,et al.  Infective endocarditis: a comprehensive overview. , 2012, Reviews in cardiovascular medicine.

[2]  C. Stanescu,et al.  Endocarditis in the 21(st) Century. , 2011, Maedica.

[3]  A. Saxena,et al.  Prospective study of infective endocarditis from a developing country. , 2011, American heart journal.

[4]  P. Tornos,et al.  Infective endocarditis: the European viewpoint. , 2011, Current problems in cardiology.

[5]  M. C. Nunes,et al.  Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  M. Aksoy,et al.  Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region. , 2010, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[7]  Carol Phillips,et al.  The ecology, epidemiology and virulence of Enterococcus. , 2009, Microbiology.

[8]  Andrew Wang,et al.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. , 2009, Archives of internal medicine.

[9]  A. Kamarulzaman.  International Collaboration on Endocarditis Prospective Cohort Study , 2008 .

[10]  I. Trabelsi,et al.  Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). , 2008, The American journal of cardiology.

[11]  D. Murdoch,et al.  Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. , 2008, Archives of internal medicine.

[12]  S. Shahsavan,et al.  Emergence of High-Level Vancomycin-Resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran , 2008, Medical Principles and Practice.

[13]  J. Patel,et al.  Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Mohamed Chakroun,et al.  Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[15]  Patricia Muñoz,et al.  Contemporary clinical profile and outcome of prosthetic valve endocarditis. , 2007, JAMA.

[16]  H Helenius,et al.  Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980–2004 , 2006, Heart.

[17]  J. Casabé,et al.  Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la República Argentina-2 (EIRA-2) Study. , 2006, American heart journal.

[18]  K. Anstrom,et al.  Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, JAMA.

[19]  N. Sinha,et al.  Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992-2001. , 2005, International journal of cardiology.

[20]  Outi Lyytikäinen,et al.  Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002 , 2004, Emerging infectious diseases.

[21]  G. Wilkins,et al.  Review of 65 cases of infective endocarditis in Dunedin Public Hospital. , 2004, The New Zealand medical journal.

[22]  D. Livermore,et al.  Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. , 2004, The Journal of antimicrobial chemotherapy.

[23]  R. Smego,et al.  Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan. , 2004, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[24]  L. Olaison,et al.  A Clinical Study of Culture-Negative Endocarditis , 2003, Medicine.

[25]  G. Baron,et al.  Infective endocarditis in Europe: lessons from the Euro heart survey , 2003, Heart.

[26]  S. Eykyn,et al.  Left atrial thrombus caused by the primary antiphospholipid syndrome causing critical functional mitral stenosis , 2003, Heart.

[27]  C. Leport,et al.  The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. , 2002, The Journal of infection.

[28]  N. Woodford.  Vancomycin resistant Staphylococcus aureus in the United States , 2002 .

[29]  F. Alla,et al.  Changing profile of infective endocarditis: results of a 1-year survey in France. , 2002, JAMA.

[30]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  F. Grover,et al.  Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1994, The Journal of thoracic and cardiovascular surgery.

[32]  W J Martone,et al.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. , 1992, Infection control and hospital epidemiology.

[33]  L. Weinstein,et al.  Infective endocarditis in the antibiotic era. , 1966, The New England journal of medicine.

[34]  A. Abdollahi,et al.  Changes in 4-year antimicrobial resistance pattern of gram-positive bacteria at the main referral teaching hospital, Tehran, Iran. , 2012, Acta medica Iranica.

[35]  V. Fowler,et al.  Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. , 2011, Future microbiology.

[36]  S. Khoshhal,et al.  INFECTIVE ENDOCARDITIS IN INTRAVENOUS DRUG USERS, EVALUATION OF CLINICAL AND PARA-CLINICAL PRESENTATION , 2011 .

[37]  Anil Kumar Singh,et al.  Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). , 2008, Journal of medical microbiology.

[38]  M. Mahmoudi,et al.  ENDOCARDITIS WITH AN UNCOMMON GERM , 2006 .

[39]  Y. Consejo.  Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: A national survey. The Endocarditis Infecciosa en la República Argentina-2(EIRA-2) Study , 2006 .

[40]  M Abbott,et al.  Methicillin-resistant Staphylococcus aureus from Europe. , 1992, The Journal of hospital infection.

[41]  Dismukes We.  Management of infective endocarditis. , 1981, Cardiovascular clinics.

[42]  C. Watanakunakorn.  Changing epidemiology and newer aspects of infective endocarditis. , 1977, Advances in internal medicine.

[43]  M. Herregods,et al.  Clinical Research Valvular Heart Disease , 2022 .

[44]  I NFECTIVE E NDOCARDITIS IN A DULTS , 2022 .